Jobs
View more job listings or post a job
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Variant Bio (Senior) Scientist - DMPK
Alturas Analytics Scientist 1
University of California, Davis TOXICOLOGY ANALYTICAL CHEMIST (STAFF RESEARCH ASSOCIATE 3)
University of California, Davis CALIFORNIA ANIMAL HEALTH AND FOOD SAFETY LABORATORY - TOXICOLOGY LAB RESEARCH SUPERVISOR/GROUP LEADER
Eli Lilly and Company R-39973 Scientific Director ADME - Novel Modalities (Open)
FibroGen Director DMPK
Applied BioMath Technical Marketing Specialist
Horizon Therapeutics Director, Bioanalytical Sciences
Exelixis Principal Scientist - DMPK
Post a job
Symposium

[Free Online] Artificial Intelligence and Machine Learning to Drive Therapeutic Drug Discovery & Development


Speakers: Alex Zhavoronkov, Insilico Medicine; Abraham Heifets, Atomwise; Stephen MacKinnon, Recursion; Charles Fisher, Unlearn; Karen Akinsanya, Schrodinger; Jason Rolfe, Variational AI; Sang Eun Jee, XtalPi; Ci Chu, insitro
Organizers: Kevin McLure (Ermaris Bio)
Date: 2023-12-06- 12/07/2023
Time: 8:30-13:00 Pacific Time
Registration fee: Free
Location: Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2023-12-05  (it will close sooner if the seating cap is reached)

About the Topic

Dec. 6th

PST

EST

Topic

Presenter

8:30-8:40am

11:30-11:40am

Welcome Remarks

Kevin McLure, PhD (Ermaris Bio)

8:40-9:35am

11:40am-12:35pm

Generative AI and Robotics for end-to-end drug discovery and development from case studies to clinic

Alex Zhavoronkov, PhD, CEO & Founder,Insilico Medicine

9:35-10:30am

12:35-1:30pm

AI for drug discovery: what it can do and can't do, what it should do and shouldn't do

Abraham Heifets, PhD, CEO & Co-founder, Atomwise

10:30-10:40am

1:30-1:40pm

Break

-

10:40-11:35am

1:40-2:35pm

Massive Scale Chemoproteomic Profiling Using Drug Target
Interaction (DTI) Prediction Models

Stephen MacKinnon, PhD, VP Digital Chemistry, Recursion (Cyclica)

11:35am-12:30pm

2:35-3:30pm

Enabling efficient cliical trials with generative models for clinical timeseries

Charles Fisher, PhD, CEO & Founder, Unlearn

12:30-1:00pm

3:30-4:00pm

Panel Discussion

All Speakers

Dec. 7th

PST

EST

Topic

Presenter

8:30-8:40am

11:30-11:40am

Welcome Remarks

Kevin McLure, PhD (Ermaris Bio)

8:40-9:35am

11:40am-12:35pm

New dimensions: how computation is accelerating structure-based drug design

Karen Akinsanya, PhD, President of R&D, Therapeutics, Schrodinger

9:35-10:30am

12:35-1:30pm

Bridging the gap between AI and drug discovery

Jason Rolfe, PhD, CTO & Co-Founder, Variational AI

10:30-10:40am

1:30-1:40pm

Break

-

10:40-11:35am

1:40-2:35pm

Accelerate drug discovery using intelligent computing and automated synthesis

Sang Eun Jee, PhD, Application Scientist, XtalPi

11:35am-12:30pm

2:35-3:30pm

Machine learning enabled target discovery in human cellular disease models

Ci Chu, PhD, Sr Director, Head of Advanced Cellular Technologies, insitro

12:30-1:00pm

3:30-4:00pm

Panel Discussion

All Speakers

Sponsored by Veloxity


About the Speakers

Dec 6th:
Alex Zhavoronkov, PhD,CEO & Founder, Insilico Medicine
Abraham Heifets, PhD,CEO & Co-founder, Atomwise
Stephen Mackinnon, PhD, VP Digital Chemistry, Recursion (Cyclica)
Charles Fisher, PhD, CEO & Founder, Unlearn
Dec. 7th:
Karen Akinsanya, PhD, President of R&D, Therapeutics, Schrodinger
Jason Rolfe, PhD, CTO & Co-Founder, Variational AI
Sang Eun Jee, PhD, Application Scientist, XtalPi
Ci Chu, PhD, Sr Director, Head of Advanced Cellular Technologies, insitro

Other Events of PBSS-San Francisco Bay:

2024-05-06, [In-Person] Human Mass Balance and Metabolite Profiling Studies: Strategies, Technical Approaches, Regulatory Guidance, Applications and Case Studies
2024-05-13, [Free Online] Highlights of 2023 FDA Drug Approvals
2024-05-21, [In-Person] Nonclinical Safety Studies for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
2024-05-30, [Free Online Workshop] Career Transition for Research Scientists: Career Overview, Project Management and Regulatory Affairs (jointly with BioPharmaPM and RAPS-SF)
2024-06-13, [In-Person] CMC Strategies and Activities for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
2024-06-20, Alzheimer's Disease: Untangling What We Thought We Knew and Future Precision Diagnostics and Therapeutics
2024-07-24, [Free Online] The Science and Stories of Promising Biotech Startups: Symposium No.6
2024-09-10, [In-Person] Rethinking Translational PK/PD and Human Dose Projections for Novel Therapeutic Modalities: Covalent Inhibitors, PROTACs, Molecular Glues, ADCs, Ocular and Neuro Delivery, Vaccines, Bispecifics, Cell and Gene Therapies
2024-09-20, [In-Person] Non-clinical Safety Assessments of Biologics and Other Novel Modalities for IND/NDA/BLA Filings: Nuts, Bolts and Best Practices
2024-10-10, [In-Person] Regulatory Global Submission: Strategies and Best Practices for FDA, EMA and PMDA
©Pharmaceutical & BioScience Society, International; Last Modified: 5/2/2024; Admin Logon
 Ads (in random order)
Submit a Text Ad
($250 for 2 months)
Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Lena Biosciences Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Lena Biosciences Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
Submit a Text Ad